ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Differential Tissue-Coupled Powering for Battery-Free Injectable Electroceuticals.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Electroceutical implants that deliver targeted neural stimulation have shown therapeutic potential for a wide range of neurological and peripheral disorders, yet wirelessly powering ultra-miniaturized, fully injectable systems remains a critical challenge. Here, we report a Thread-like Injectable Neural TechnologY (TINY) based on differential tissue-coupled powering (DTCP), which transmits energy through tissue using MHz-range differential fields generated by a compact, wearable transmitter. DTCP allows power harvesting to scale with implant length rather than cross-section, enabling a flexible, thread-like implant that integrates a custom ASIC with PEDOT-coated receiver and stimulation electrodes. Benchtop experiments in tissue-mimicking agar phantoms characterize power-transfer efficiency (PTE) and reveal that PTE increases with implant length while remaining highly tolerant to angular misalignment. In vivo tests in rat hindlimbs further demonstrate wireless sciatic nerve activation through tissue at centimeter-scale depths, confirming effective transcutaneous energy delivery for neurostimulation. A 20-day implantation study provides a short-term/subacute assessment of device positioning and local tissue response. Together, these findings address long-standing challenges in wirelessly powering injectable electroceuticals and establish DTCP as a scalable and alignment-robust powering strategy for future minimally invasive neuromodulation therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.